Suppr超能文献

日本恶性黑色素瘤患者病灶及尿液中的半胱氨酰多巴异构体和多巴

Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.

作者信息

Morishima T, Tatsumi F, Fukada E, Saito M, Fujita M, Nagashima N, Hanawa S

出版信息

Arch Dermatol Res. 1983;275(2):76-9. doi: 10.1007/BF00412878.

Abstract

Cysteinyldopas and Dopa in the urine and tissues of Japanese melanoma patients were investigated quantitatively by means of high-performance liquid chromatography. Cysteinyldopa isomers were detected in the urine of eumelanic Japanese patients. The amount (X +/- SD%) of each isomer of cysteinyldopa in the urine was 80.26 +/- 4.66% in 5-S-cysteinyldopa, 9.39 +/- 1.64% in 2-S-cysteinyldopa, 7.07 +/- 3.33% in 2, 5-S, S-dicysteinyldopa, and 3.28 +/- 1.43% in 6-S-cysteinyldopa. The amount of cysteinyldopa in melanoma tissues was 26-314 times more than that of Dopa. The amount (X +/- SD%) of cysteinyldopa in the tissues was 80.34 +/- 1.75% in 5-S-cysteinyldopa, 11.06 +/- 1.91% in 2-S-cysteinyldopa, 6.27 +/- 1.43% in 2, 5-S, S-dicysteinyldopa, and 2.34 +/- 0.61% in 6-S-cysteinyldopa. The fact that the percentages of each isomer of cysteinyldopa in the urine and in the tissues were approximately constant suggests that the cysteinyldopas secreted from melanoma cells were excreted into the urine without being metabolized.

摘要

采用高效液相色谱法对日本黑色素瘤患者尿液和组织中的半胱氨酰多巴及多巴进行了定量研究。在真黑素性日本患者的尿液中检测到了半胱氨酰多巴异构体。尿液中每种半胱氨酰多巴异构体的含量(X±SD%)分别为:5-S-半胱氨酰多巴80.26±4.66%,2-S-半胱氨酰多巴为9.39±1.64%,2,5-S,S-二半胱氨酰多巴为7.07±3.33%,6-S-半胱氨酰多巴为3.28±1.43%。黑色素瘤组织中半胱氨酰多巴的含量比多巴高26 - 314倍。组织中半胱氨酰多巴的含量(X±SD%)分别为:5-S-半胱氨酰多巴80.34±1.75%,2-S-半胱氨酰多巴为11.06±1.91%,2,5-S,S-二半胱氨酰多巴为6.27±1.43%,6-S-半胱氨酰多巴为2.34±0.61%。尿液和组织中半胱氨酰多巴各异构体的百分比大致恒定,这一事实表明,黑色素瘤细胞分泌的半胱氨酰多巴未经代谢就排泄到了尿液中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验